Traws Pharma, Inc. (TRAW)

Traws Pharma Revenue

Traws Pharma had revenue of $2.73M in the twelve months ending March 31, 2026, up 1,103.96% year-over-year. In the year 2025, Traws Pharma had annual revenue of $2.79M with 1,134.51% growth.

• Revenue (ttm): $2.73M
• Revenue Growth: +1,103.96%
• P/S Ratio: 7.87
• Revenue / Employee: $390,429
• Employees: 7
• Market Cap: 21.51M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.79M	2.56M	1,134.51%
Dec 31, 2024	226.00K	-	-
Dec 31, 2023	226.00K	-	-
Dec 31, 2022	226.00K	-	-
Dec 31, 2021	226.00K	-5.00K	-2.16%
Dec 31, 2020	231.00K	-1.95M	-89.42%
Dec 31, 2019	2.18M	955.00K	77.77%
Dec 31, 2018	1.23M	441.00K	56.04%
Dec 31, 2017	787.00K	-4.76M	-85.81%
Dec 31, 2016	5.55M	-5.91M	-51.59%
Dec 31, 2015	11.46M	10.66M	1,332.00%
Dec 31, 2014	800.00K	-3.95M	-83.17%
Dec 31, 2013	4.75M	-41.44M	-89.71%
Dec 31, 2012	46.19M	44.70M	3,006.25%
Dec 31, 2011	1.49M	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error